The forces that have shaped American medicine include a wide set of interrelated changes, among them the changing research, development, and marketing practices of the pharmaceutical industry. This article compares the research and development (R&D) and marketing strategies of the British group Imperial Chemical Industries (ICI, whose Pharmaceutical Division was spun off and merged with the Swedish company Astra to form AstraZeneca) and its French counterpart Rhône-Poulenc (now part of Sanofi-Aventis) in dealing with the American medical market. It examines how, in the process, the relationship between R&D and marketing was altered, and the firms themselves were transformed. The article also questions the extent to which their approaches to this market, one of the most significant markets for drugs in general, and for anticancer drugs in particular, became standardized in the period of “scientific marketing.”
...More
Article
Thoms, Ulrike;
(2013)
Standardizing Selling. Pharmaceutical Marketing, the Pharmaceutical Company and the Marketing Expert (1900--1980)
(/isis/citation/CBB001320755/)
Article
Jacalyn Duffin;
(2020)
The Yew Tree and the Crab: A Case Study of Big Pharma, Small Pharma, and an Anti-Cancer Drug
(/isis/citation/CBB756855341/)
Article
Quirke, Viviane;
(2006)
Putting Theory into Practice: James Black, Receptor Theory and the Development of the Beta-Blockers at ICI, 1958--1978
(/isis/citation/CBB000773951/)
Article
Podolsky, Scott H.;
Greene, Jeremy A.;
(2009)
Keeping Modern in Medicine: Pharmaceutical Promotion and Physician Education in Postwar America
(/isis/citation/CBB000932130/)
Article
Greene, Jeremy A.;
(2013)
The Materiality of the Brand: Form, Function, and the Pharmaceutical Trademark
(/isis/citation/CBB001320757/)
Book
Greene, Jeremy A.;
Watkins, Elizabeth Siegel;
(2012)
Prescribed: Writing, Filling, Using, and Abusing the Prescription in Modern America
(/isis/citation/CBB001214574/)
Book
Jones, Claire;
(2013)
The Medical Trade Catalogue in Britain, 1870--1914
(/isis/citation/CBB001202367/)
Article
Giulia Bovone;
(2020)
Bioplastina Serono: il ricostituente preferito dagli italiani (XX secolo)
(/isis/citation/CBB350646575/)
Article
Enrico Cevolani;
(2020)
Dai cerotti Plastod all’Idrobitume: le invenzioni di Umberto Dotta, chimico e farmacista bolognese
(/isis/citation/CBB399905160/)
Book
Almond, Peter R.;
(2013)
Cobalt Blues: The Story of Leonard Grimmett, the Man behind the First Cobalt-60 Unit in the United States
(/isis/citation/CBB001213187/)
Thesis
Quinn, Roswell;
(2009)
Broader Spectrum: A History of Antibiotic R&D
(/isis/citation/CBB001560664/)
Article
Bonah, Christian;
(2013)
“The Strophanthin Question”: Early Scientific Marketing of Cardiac Drugs in Two National Markets (France and Germany, 1900--1930).
(/isis/citation/CBB001320753/)
Article
Viviane Quirke;
(2020)
Imperial Chemical Industries and Craig Jordan, “the First Tamoxifen Consultant,” 1960s–1990s
(/isis/citation/CBB851153384/)
Article
Gaudillière, Jean-Paul;
(2013)
From Propaganda to Scientific Marketing: Schering, Cortisone, and the Construction of Drug Markets
(/isis/citation/CBB001320756/)
Book
Shorter, Edward;
(2009)
Before Prozac: The Troubled History of Mood Disorders in Psychiatry
(/isis/citation/CBB000952059/)
Book
Martin Saxer;
(2013)
Manufacturing Tibetan Medicine: The Creation of an Industry and the Moral Economy of Tibetanness
(/isis/citation/CBB931416500/)
Article
Ilenia Garoia;
(2017)
Farmacista, preparatore, comunicatore, innovatore: il caso Oreste Ruggeri (1857-1912)
(/isis/citation/CBB233428609/)
Article
Sharma, Padmanee;
Allison, James P.;
(2012)
Lloyd J. Old (1933--2011)
(/isis/citation/CBB001320473/)
Book
Avorn, Jerry;
(2004)
Powerful Medicines: The Benefits, Risks and Costs of Prescription Drugs
(/isis/citation/CBB000830813/)
Article
Tweedale, Geoffrey;
McCulloch, Jock;
(2004)
Chrysophiles versus Chrysophobes: The White Asbestos Controversy, 1950s--2004
(/isis/citation/CBB000470999/)
Be the first to comment!